Subject category:
Strategy and General Management
Published by:
Ivey Publishing
Version: 2009-10-22
Length: 3 pages
Data source: Field research
Share a link:
https://casecent.re/p/14379
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is a supplement to BLES Biochemicals Inc (A), ''9B03M026''. The (A) case explores the growth options available to a new biotech company with a revolutionary drug for premature infants. There seems to be a significant potential for international growth. The (B) case takes place six months later when the president of the company obtains new data concerning market size projections, technological advances and competitor actions that require him to reconsider the company''s strategic positioning and plans for international expansion.
Subject category:
Strategy and General Management
Published by:
Ivey Publishing
Version: 2009-10-22
Length: 19 pages
Data source: Field research
About
Abstract
This is a supplement to BLES Biochemicals Inc (A), ''9B03M026''. The (A) case explores the growth options available to a new biotech company with a revolutionary drug for premature infants. There seems to be a significant potential for international growth. The (B) case takes place six months later when the president of the company obtains new data concerning market size projections, technological advances and competitor actions that require him to reconsider the company''s strategic positioning and plans for international expansion.
Settings
Related
Subject category:
Strategy and General Management
Published by:
Ivey Publishing
Version: 2009-10-22
Length: 19 pages
Data source: Field research